Green Thumb Industries (OTC:GTBIF) Upgraded at Roth Capital

Roth Capital upgraded shares of Green Thumb Industries (OTC:GTBIFFree Report) to a strong-buy rating in a research report released on Sunday,Zacks.com reports.

A number of other equities analysts also recently issued reports on the company. Ventum Cap Mkts raised Green Thumb Industries to a “strong-buy” rating in a research note on Tuesday, August 6th. Craig Hallum raised Green Thumb Industries to a “strong-buy” rating in a research report on Monday, September 16th.

Check Out Our Latest Stock Analysis on Green Thumb Industries

Green Thumb Industries Trading Down 12.5 %

Shares of GTBIF stock opened at $7.80 on Friday. The stock has a market cap of $1.65 billion, a P/E ratio of 28.90 and a beta of 1.40. The stock’s 50 day simple moving average is $10.26. Green Thumb Industries has a 12-month low of $7.50 and a 12-month high of $16.33.

Green Thumb Industries Company Profile

(Get Free Report)

Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.

Featured Articles

Receive News & Ratings for Green Thumb Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Green Thumb Industries and related companies with MarketBeat.com's FREE daily email newsletter.